Production and characterization of site-directed antibodies against dermorphin and dermorphin-related peptides.
To detect and purify endogenous dermorphin-like molecules in mammalian tissues, an immunological approach was developed. Site-directed antibodies against synthetic dermorphin and related dermorphin peptides were produced. The immunogenic forms of dermorphin were selected to obtain antibodies recognizing different epitopes overlapping the whole dermorphin molecule. One of them specifically recognized the crucial "opioid message" (the N-terminal part of the molecule), which is required for a ligand to exert its full opioid activity. The validity of our immunological approach was analyzed by studying the dermorphin-related peptide distribution in Phyllomedusa sauvagei skin. The finding that tetrapeptide Y-A-G-F-OH was present in Phyllomedusa sauvagei extracts suggested that either the Tyr3-Pro6 peptidic bond may be relatively unstable or endogenous proteolytic enzymes present in Phyllomedusa skin may inactivate this peptidic bond.
Institut de Pharmacologie Moléculaire et Cellulaire CNRS-UPR411, Valbonne, France.
K
K
Cucumel
I
I
Garreau
J
J
Mery
D
D
Moinier
A
A
Mansour
H
H
Akil
A
A
Cupo
D000701:Analgesics, Opioid / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D000918:Antibody Specificity; D001001:Anura; D002851:Chromatography, High Pressure Liquid; D004305:Dose-Response Relationship, Drug; D000939:Epitopes; D005769:Gastrointestinal Motility / Q000187:drug effects; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects; D009842:Oligopeptides / Q000276:immunology* / Q000378:metabolism; D018847:Opioid Peptides; D011863:Radioimmunoassay; D011869:Radioligand Assay; D051381:Rats; D017450:Receptors, Opioid, mu / Q000235:genetics / Q000378:metabolism; D017421:Sequence Analysis; D012867:Skin / Q000737:chemistry*
D000701:Analgesics, Opioid; D000939:Epitopes; D009842:Oligopeptides; D018847:Opioid Peptides; D017450:Receptors, Opioid, mu; C030058:dermorphin